CMA sends third SO in hydrocortisone probe

The UK’s Competition and Markets Authority has provisionally found that drugmakers Auden McKenzie and Waymade artificially inflated prices of a life-saving drug through a pay-for-delay scheme.


Get unlimited access to all Global Competition Review content